抗糖尿病薬の世界市場:種類別(経口薬、注射薬)、用途別(1型糖尿病、2型糖尿病、妊娠性糖尿病、その他)、地域別予測

◆英語タイトル:Global Antidiabetic Drug Market Size study, by Type (Oral Drugs, Injectable Drugs), by Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes Mellitus, Others) and Regional Forecasts 2018-2025
◆商品コード:BZW9JN070
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2018年12月31日
◆ページ数:約150
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、日本、アメリカ、カナダ、イギリス、ドイツ、フランス、中国、インド、ブラジル、メキシコ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD3,950 ⇒換算¥434,500見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD5,550 ⇒換算¥610,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本資料は、抗糖尿病薬の世界市場について調べ、抗糖尿病薬の世界規模、市場動向、市場環境、種類別(経口薬、注射薬)分析、用途別(1型糖尿病、2型糖尿病、妊娠性糖尿病、その他)分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。業界の主要なプレイヤーはEli Lilly、Novartis、Boehringer Ingelheim 、Merck、Novo Nordisk、Sanofi、Astra Zeneca 、Takeda、Bayer、Pfizerなどです。
・イントロダクション
・エグゼクティブサマリー
・抗糖尿病薬の世界市場概要
・抗糖尿病薬の世界市場環境
・抗糖尿病薬の世界市場動向
・抗糖尿病薬の世界市場規模
・抗糖尿病薬の世界市場規模:種類別(経口薬、注射薬)
・抗糖尿病薬の世界市場規模:用途別(1型糖尿病、2型糖尿病、妊娠性糖尿病、その他)
・抗糖尿病薬の世界市場:地域別市場規模・分析
・抗糖尿病薬の北米市場規模・予測
・抗糖尿病薬のアメリカ市場規模・予測
・抗糖尿病薬のヨーロッパ市場規模・予測
・抗糖尿病薬のアジア市場規模・予測
・抗糖尿病薬の日本市場規模・予測
・抗糖尿病薬の中国市場規模・予測
・関連企業情報
【レポートの概要】

Global Antidiabetic Drug Market to reach USD XX billion by 2025.

Global Antidiabetic Drug Market valued approximately USD 49.60 billion in 2017 is anticipated to grow with a healthy growth rate of more than 10.20% over the forecast period 2018-2025. The Antidiabetic Drug Market is continuously growing on surging trend across the world over the coming years. The major driving factor of global Antidiabetic Drug market are rising cases of diabetes and changing lifestyle. In addition, rising demand for oral anti-diabetic drugs and increasing the percentage of obesity are also some major driving factor which fueling the market growth. However, one of the major restraining factor of global antidiabetic market are high cost of the drugs. Antidiabetic drugs is a type of drug which used in diabetes to treat diabetes mellitus. Diabetes mellitus is a type of short period comprehensive disease. It is mainly caused by glucose metabolism disorder due to absolute or relatively deficiency of insulin. The occurrence of Type 2 diabetes mellitus is a combination of peripheral insulin resistance and B cell dysfunction. Optimal treatment for type 2 should aim to improve insulin resistance and cardiovascular risk factor in addition to achieve glycemic control.
The regional analysis of Global Antidiabetic Drug Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the dominant region across the world in terms of market share owing to high market penetration of modern insulin and presence of high health expenditure. Asia-Pacific is also anticipated higher growth rate / CAGR over the forecast period 2018-2025 due to rapidly improving healthcare expenditure levels, growing prevalence of Type 1 and Type 2 diabetes and increasing patient disposable income.
The major market player included in this report are:
• Eli Lilly
• Novartis
• Boehringer Ingelheim
• Merck
• Novo Nordisk
• Sanofi
• Astra Zeneca
• Takeda
• Bayer
• Pfizer

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

 Oral Drugs
 Injectable Drugs

By Application:

 Type 1 Diabetes
 Type 2 Diabetes
 Gestational Diabetes Mellitus
 Others

By Regions:
 North America
o U.S.
o Canada
 Europe
o UK
o Germany
 Asia Pacific
o China
o India
o Japan
 Latin America
o Brazil
o Mexico
 Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2015, 2016
Base year – 2017
Forecast period – 2018 to 2025

Target Audience of the Global Antidiabetic Drug Market in Market Study:

 Key Consulting Companies & Advisors
 Large, medium-sized, and small enterprises
 Venture capitalists
 Value-Added Resellers (VARs)
 Third-party knowledge providers
 Investment bankers
 Investors

【レポートの目次】

TABLE OF CONTENTS

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Key Trends
1.3. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
1.3.1. Antidiabetic Drug Market, by Type, 2015-2025 (USD Billion)
1.3.2. Antidiabetic Drug Market, by Application, 2015-2025 (USD Billion)
1.3.3. Antidiabetic Drug Market, by Region, 2015-2025 (USD Billion)
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Antidiabetic Drug Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Antidiabetic Drug Market Dynamics
3.1. See Saw Analysis
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Antidiabetic Drug Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.2. PEST Analysis
4.2.1. Political Scenario
4.2.2. Economic Scenario
4.2.3. Social Scenario
4.2.4. Technological Scenario
4.3. Value Chain Analysis
4.3.1. Supplier
4.3.2. Manufacturers/Service Provider
4.3.3. Distributors
4.3.4. End-Users
4.4. Key Buying Criteria
4.5. Regulatory Framework
4.6. Cost Structure Analysis
4.6.1. Raw Material Cost Analysis
4.6.2. Manufacturing Cost Analysis
4.6.3. Labour Cost Analysis
4.7. Investment Vs Adoption Scenario
4.8. Analyst Recommendation & Conclusion
Chapter 5. Antidiabetic Drug Market, by Type
5.1. Market Snapshot
5.2. Market Performance – Potential Model
5.3. Key Market Players
5.4. Antidiabetic Drug Market, Sub Segment Analysis
5.4.1. Oral Drugs
5.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.4.2. Injectable Drugs
5.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 6. Antidiabetic Drug Market, by Application
6.1. Market Snapshot
6.2. Market Performance – Potential Model
6.3. Key Market Players
6.4. Antidiabetic Drug Market, Sub Segment Analysis
6.4.1. Type 1 Diabetes
6.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.2. Type 2 Diabetes
6.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.3. Gestational Diabetes Mellitus
6.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.4. Others
6.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 7. Antidiabetic Drug Market, by Regional Analysis
7.1. Antidiabetic Drug Market, Regional Market Snapshot (2015-2025)
7.2. North America Antidiabetic Drug Market Snapshot
7.2.1. U.S.
7.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.2.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.2. Canada
7.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.2.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3. Europe Antidiabetic Drug Market Snapshot
7.3.1. U.K.
7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.2. Germany
7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.3. France
7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.3.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.3.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.3.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.4. Rest of Europe
7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.4.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.4.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.4.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4. Asia Antidiabetic Drug Market Snapshot
7.4.1. China
7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.2. India
7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.3. Japan
7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.3.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.3.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.3.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.4. Rest of Asia Pacific
7.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.4.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.4.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.4.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5. Latin America Antidiabetic Drug Market Snapshot
7.5.1. Brazil
7.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.5.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.2. Mexico
7.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.5.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6. Rest of The World
7.6.1. South America
7.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.6.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.2. Middle East and Africa
7.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.6.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 8. Competitive Intelligence
8.1. Company Market Share (Subject to Data Availability)
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Eli Lilly
8.3.1.1. Overview
8.3.1.2. Financial (Subject to Data Availability)
8.3.1.3. Product Summary
8.3.1.4. Recent Developments
8.3.2. Novartis
8.3.3. Boehringer Ingelheim
8.3.4. Merck
8.3.5. Novo Nordisk
8.3.6. Sanofi
8.3.7. Astra Zeneca
8.3.8. Takeda
8.3.9. Bayer
8.3.10. Pfizer
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.1.6. Research Assumption

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF ANTIDIABETIC DRUG MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF ANTIDIABETIC DRUG MARKET
TABLE 3. ANTIDIABETIC DRUG MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. ANTIDIABETIC DRUG MARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD BILLION)
TABLE 7. ANTIDIABETIC DRUG MARKET ESTIMATES & FORECASTS BY COMPONENT 2015-2025 (USD BILLION)
TABLE 8. ANTIDIABETIC DRUG MARKET ESTIMATES & FORECASTS BY TYPE 2015-2025 (USD BILLION)
TABLE 9. ANTIDIABETIC DRUG MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 10. ANTIDIABETIC DRUG MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 11. ANTIDIABETIC DRUG MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 12. ANTIDIABETIC DRUG MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 13. ANTIDIABETIC DRUG MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 14. ANTIDIABETIC DRUG MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 15. ANTIDIABETIC DRUG MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 16. ANTIDIABETIC DRUG MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 17. ANTIDIABETIC DRUG MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 18. ANTIDIABETIC DRUG MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 19. ANTIDIABETIC DRUG MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 20. ANTIDIABETIC DRUG MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 21. ANTIDIABETIC DRUG MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 22. ANTIDIABETIC DRUG MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 23. ANTIDIABETIC DRUG MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 24. ANTIDIABETIC DRUG MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 25. ANTIDIABETIC DRUG MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 26. ANTIDIABETIC DRUG MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 27. ANTIDIABETIC DRUG MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 28. ANTIDIABETIC DRUG MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 29. ANTIDIABETIC DRUG MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 30. ANTIDIABETIC DRUG MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 31. ANTIDIABETIC DRUG MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 32. ANTIDIABETIC DRUG MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 33. ANTIDIABETIC DRUG MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 34. ANTIDIABETIC DRUG MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 35. ANTIDIABETIC DRUG MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 36. ANTIDIABETIC DRUG MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 37. ANTIDIABETIC DRUG MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 38. ANTIDIABETIC DRUG MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 39. ANTIDIABETIC DRUG MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 40. ANTIDIABETIC DRUG MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 41. ANTIDIABETIC DRUG MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 42. ANTIDIABETIC DRUG MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 43. ANTIDIABETIC DRUG MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 44. ANTIDIABETIC DRUG MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 45. U.S. ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 46. U.S. ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 47. U.S. ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 48. U.S. ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 49. U.S. ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 50. CANADA ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 51. CANADA ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 52. CANADA ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 53. CANADA ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 54. CANADA ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 55. UK ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 56. UK ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 57. UK ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 58. UK ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 59. UK ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 60. GERMANY ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 61. GERMANY ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 62. GERMANY ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 63. GERMANY ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 64. GERMANY ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 65. ROE ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 66. ROE ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 67. ROE ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 68. ROE ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 69. ROE ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 70. CHINA ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 71. CHINA ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 72. CHINA ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 73. CHINA ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 74. CHINA ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 75. INDIA ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 76. INDIA ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 77. INDIA ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 78. INDIA ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 79. INDIA ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 80. JAPAN ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 81. JAPAN ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 82. JAPAN ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 83. JAPAN ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 84. JAPAN ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 85. ROAPAC ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 86. ROAPAC ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 87. ROAPAC ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 88. ROAPAC ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 89. ROAPAC ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 90. BRAZIL ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 91. BRAZIL ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 92. BRAZIL ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 93. BRAZIL ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 94. BRAZIL ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 95. MEXICO ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 96. MEXICO ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 97. MEXICO ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 98. MEXICO ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 99. MEXICO ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 100. ROLA ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 101. ROLA ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 102. ROLA ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 103. ROLA ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 104. ROLA ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 105. ROW ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 106. ROW ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 107. ROW ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 108. ROW ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 109. ROW ANTIDIABETIC DRUG MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

FIG 1. ANTIDIABETIC DRUG MARKET, RESEARCH METHODOLOGY
FIG 2. ANTIDIABETIC DRUG MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. ANTIDIABETIC DRUG MARKET, KEY TRENDS 2016
FIG 5. ANTIDIABETIC DRUG MARKET, GROWTH PROSPECTS 2017-2025
FIG 6. ANTIDIABETIC DRUG MARKET, PORTERS 5 FORCE MODEL
FIG 7. ANTIDIABETIC DRUG MARKET, PEST ANALYSIS
FIG 8. ANTIDIABETIC DRUG MARKET, VALUE CHAIN ANALYSIS
FIG 9. ANTIDIABETIC DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 10. ANTIDIABETIC DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 11. ANTIDIABETIC DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 12. ANTIDIABETIC DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 13. ANTIDIABETIC DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 14. ANTIDIABETIC DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 15. ANTIDIABETIC DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 16. ANTIDIABETIC DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 17. ANTIDIABETIC DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 18. ANTIDIABETIC DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 19. ANTIDIABETIC DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 20. ANTIDIABETIC DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 21. ANTIDIABETIC DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 22. ANTIDIABETIC DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 23. ANTIDIABETIC DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 24. ANTIDIABETIC DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 25. ANTIDIABETIC DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 26. ANTIDIABETIC DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 27. ANTIDIABETIC DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 28. ANTIDIABETIC DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 29. ANTIDIABETIC DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 30. ANTIDIABETIC DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 31. ANTIDIABETIC DRUG MARKET, REGIONAL SNAPSHOT 2015 & 2025
FIG 32. NORTH AMERICA ANTIDIABETIC DRUG MARKETMARKET 2015 & 2025 (USD BILLON)
FIG 33. EUROPE ANTIDIABETIC DRUG MARKETMARKET 2015 & 2025 (USD BILLON)
FIG 34. ASIA PACIFIC ANTIDIABETIC DRUG MARKETMARKET 2015 & 2025 (USD BILLON)
FIG 35. LATIN AMERICA ANTIDIABETIC DRUG MARKETMARKET 2015 & 2025 (USD BILLON)
FIG 36. ANTIDIABETIC DRUG MARKET, COMPANY MARKET SHARE ANALYSIS (2016)

【掲載企業】

Eli Lilly、Novartis、Boehringer Ingelheim 、Merck、Novo Nordisk、Sanofi、Astra Zeneca 、Takeda、Bayer、Pfizer

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[抗糖尿病薬の世界市場:種類別(経口薬、注射薬)、用途別(1型糖尿病、2型糖尿病、妊娠性糖尿病、その他)、地域別予測]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆